Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon Jun 26, 2018 4:33pm

141 Views

Post# 28232576

RE:FINALLY...A $1.00 plus share price before the year ends!!!

myperspective wrote: followed by a hugh parabolic move to the upside sometime in the first or second quarter
of 2019!!!

Just a brief perspective using my technical analysis skills of some 40 plus years.

So, after 40 plus years you are still playing on the vulture xchange, which leads me to ask, how many times have you been wrong?

Bullboard Posts

Report: New, more dangerous malware used in increasing cyberattacks